tiprankstipranks
Foghorn Therapeutics appoints Humer as Chief Financial Officer
PremiumThe FlyFoghorn Therapeutics appoints Humer as Chief Financial Officer
1M ago
Viridian Therapeutics price target lowered to $25 from $29 at B. Riley
PremiumThe Fly
Viridian Therapeutics price target lowered to $25 from $29 at B. Riley
2M ago
Viridian Therapeutics, Inc. (VRDN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Viridian Therapeutics, Inc. (VRDN) Q4 Earnings Cheat Sheet
2M ago
Viridian Therapeutics reports Q4 EPS ($1.35), consensus ($1.00)
PremiumThe FlyViridian Therapeutics reports Q4 EPS ($1.35), consensus ($1.00)
3M ago
Viridian Therapeutics names Jennifer Tousignant chief legal officer
PremiumThe Fly
Viridian Therapeutics names Jennifer Tousignant chief legal officer
3M ago
Insider Trading: Viridian (NASDAQ:VRDN) Sees Huge Insider Buy
PremiumMarket News
Insider Trading: Viridian (NASDAQ:VRDN) Sees Huge Insider Buy
4M ago
Apogee Therapeutics price target raised to $46 from $34 at Stifel
PremiumThe FlyApogee Therapeutics price target raised to $46 from $34 at Stifel
4M ago
Short Report: Bears boost exposure to Rocket Companies despite dovish Fed tilt
PremiumThe Fly
Short Report: Bears boost exposure to Rocket Companies despite dovish Fed tilt
5M ago
Viridian Therapeutics price target raised to $36 from $35 at Oppenheimer
PremiumThe Fly
Viridian Therapeutics price target raised to $36 from $35 at Oppenheimer
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100